Parenteral dosage form of β3 adrenoreceptor agonists

Parenteral dosage form of β3 adrenoreceptor agonists

Disclosed are the injection compositions of β3 adrenoreceptor agonists such as mirabegron or their pharmaceutically acceptable salts or solvates or esters thereof. The present invention also relates to methods for preparing injection compositions and methods of using these dosage forms for the treat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Nandi, Indranil, Chikkamath, Nagabasayya R, Mukherjee, Tusharmouli
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Nandi, Indranil
Chikkamath, Nagabasayya R
Mukherjee, Tusharmouli
description Disclosed are the injection compositions of β3 adrenoreceptor agonists such as mirabegron or their pharmaceutically acceptable salts or solvates or esters thereof. The present invention also relates to methods for preparing injection compositions and methods of using these dosage forms for the treatment of obesity, other related metabolic diseases, and reduction/removal of fat. The injection compositions as per the present invention have advantages of simple preparation, simple and convenient application, easy absorption, and better effect of treating. The compositions can also be used in cases where oral administration of the drug is not possible due to underlying conditions or concerns around inadequate oral absorption. The injection compositions as per the present invention have desirable pharmaceutical technical attributes.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US11311518B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US11311518B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US11311518B13</originalsourceid><addsrcrecordid>eNrjZDANSCxKzStJLUrMUUjJL05MT1VIyy_KVchPUzi3yVghMQUom1-UmpxaUJJfpJCYnp-XWVxSzMPAmpaYU5zKC6W5GRTdXEOcPXRTC_LjU4sLEpNT81JL4kODDQ2NDQ1NDS2cDI2JUQMAtNkt-g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Parenteral dosage form of β3 adrenoreceptor agonists</title><source>esp@cenet</source><creator>Nandi, Indranil ; Chikkamath, Nagabasayya R ; Mukherjee, Tusharmouli</creator><creatorcontrib>Nandi, Indranil ; Chikkamath, Nagabasayya R ; Mukherjee, Tusharmouli</creatorcontrib><description>Disclosed are the injection compositions of β3 adrenoreceptor agonists such as mirabegron or their pharmaceutically acceptable salts or solvates or esters thereof. The present invention also relates to methods for preparing injection compositions and methods of using these dosage forms for the treatment of obesity, other related metabolic diseases, and reduction/removal of fat. The injection compositions as per the present invention have advantages of simple preparation, simple and convenient application, easy absorption, and better effect of treating. The compositions can also be used in cases where oral administration of the drug is not possible due to underlying conditions or concerns around inadequate oral absorption. The injection compositions as per the present invention have desirable pharmaceutical technical attributes.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220426&amp;DB=EPODOC&amp;CC=US&amp;NR=11311518B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220426&amp;DB=EPODOC&amp;CC=US&amp;NR=11311518B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Nandi, Indranil</creatorcontrib><creatorcontrib>Chikkamath, Nagabasayya R</creatorcontrib><creatorcontrib>Mukherjee, Tusharmouli</creatorcontrib><title>Parenteral dosage form of β3 adrenoreceptor agonists</title><description>Disclosed are the injection compositions of β3 adrenoreceptor agonists such as mirabegron or their pharmaceutically acceptable salts or solvates or esters thereof. The present invention also relates to methods for preparing injection compositions and methods of using these dosage forms for the treatment of obesity, other related metabolic diseases, and reduction/removal of fat. The injection compositions as per the present invention have advantages of simple preparation, simple and convenient application, easy absorption, and better effect of treating. The compositions can also be used in cases where oral administration of the drug is not possible due to underlying conditions or concerns around inadequate oral absorption. The injection compositions as per the present invention have desirable pharmaceutical technical attributes.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDANSCxKzStJLUrMUUjJL05MT1VIyy_KVchPUzi3yVghMQUom1-UmpxaUJJfpJCYnp-XWVxSzMPAmpaYU5zKC6W5GRTdXEOcPXRTC_LjU4sLEpNT81JL4kODDQ2NDQ1NDS2cDI2JUQMAtNkt-g</recordid><startdate>20220426</startdate><enddate>20220426</enddate><creator>Nandi, Indranil</creator><creator>Chikkamath, Nagabasayya R</creator><creator>Mukherjee, Tusharmouli</creator><scope>EVB</scope></search><sort><creationdate>20220426</creationdate><title>Parenteral dosage form of β3 adrenoreceptor agonists</title><author>Nandi, Indranil ; Chikkamath, Nagabasayya R ; Mukherjee, Tusharmouli</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US11311518B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Nandi, Indranil</creatorcontrib><creatorcontrib>Chikkamath, Nagabasayya R</creatorcontrib><creatorcontrib>Mukherjee, Tusharmouli</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Nandi, Indranil</au><au>Chikkamath, Nagabasayya R</au><au>Mukherjee, Tusharmouli</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Parenteral dosage form of β3 adrenoreceptor agonists</title><date>2022-04-26</date><risdate>2022</risdate><abstract>Disclosed are the injection compositions of β3 adrenoreceptor agonists such as mirabegron or their pharmaceutically acceptable salts or solvates or esters thereof. The present invention also relates to methods for preparing injection compositions and methods of using these dosage forms for the treatment of obesity, other related metabolic diseases, and reduction/removal of fat. The injection compositions as per the present invention have advantages of simple preparation, simple and convenient application, easy absorption, and better effect of treating. The compositions can also be used in cases where oral administration of the drug is not possible due to underlying conditions or concerns around inadequate oral absorption. The injection compositions as per the present invention have desirable pharmaceutical technical attributes.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US11311518B1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Parenteral dosage form of β3 adrenoreceptor agonists
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T17%3A18%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Nandi,%20Indranil&rft.date=2022-04-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS11311518B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true